ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Vivos Inc (QB)

Vivos Inc (QB) (RDGL)

0.1199
0.00115
(0.97%)
Closed April 25 4:00PM

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.1199
Bid
0.1185
Ask
0.12
Volume
1,061,702
0.104 Day's Range 0.124
0.04119 52 Week Range 0.124
Market Cap
Previous Close
0.11875
Open
0.1229
Last Trade
4000
@
0.1199
Last Trade Time
Financial Volume
$ 122,837
VWAP
0.115698
Average Volume (3m)
823,264
Shares Outstanding
370,994,857
Dividend Yield
-
PE Ratio
-15.38
Earnings Per Share (EPS)
-0.01
Revenue
20k
Net Profit
-2.9M

About Vivos Inc (QB)

Sector
Surgical,med Instr,apparatus
Industry
Surgical,med Instr,apparatus
Headquarters
Wilmington, Delaware, USA
Founded
1970
Vivos Inc (QB) is listed in the Surgical,med Instr,apparatus sector of the OTCMarkets with ticker RDGL. The last closing price for Vivos (QB) was $0.12. Over the last year, Vivos (QB) shares have traded in a share price range of $ 0.04119 to $ 0.124.

Vivos (QB) currently has 370,994,857 shares outstanding. The market capitalization of Vivos (QB) is $44.52 million. Vivos (QB) has a price to earnings ratio (PE ratio) of -15.38.

RDGL Latest News

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.014413.64928909950.10550.1240.09758093790.11054375CS
40.049971.28571428570.070.1240.069912718620.09962197CS
120.0638113.7254901960.05610.1240.0498232640.07973622CS
260.062107.0811744390.05790.1240.041197118940.07305332CS
520.011410.50691244240.10850.1240.041195700530.06928684CS
1560.034840.893066980.08510.140.046665570.07868726CS
2600.11673646.8750.00320.310.002510469810.07932183CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ISUNiSun Inc
$ 0.173
(84.04%)
19.93M
BRFHBarfresh Food Group Inc
$ 1.75
(69.90%)
44.33M
SGBXSafe and Green Holdings Corporation
$ 0.225
(56.14%)
136.91M
PCSAProcessa Pharmaceuticals Inc
$ 2.4137
(48.99%)
77.21M
BACKIMAC Holdings Inc
$ 5.065
(45.34%)
8.49M
EJHE Home Household Service Holdings Ltd
$ 0.767
(-73.64%)
12.36M
TVGNTevogen Bio Holdings Inc
$ 0.9057
(-39.62%)
328.69k
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.265
(-37.69%)
16.75M
ATNIATN International Inc
$ 19.24
(-33.01%)
440.2k
BNAIBrand Engagement Network Inc
$ 2.59
(-30.56%)
234.29k
SQQQProShares UltraPro Short QQQ
$ 12.00
(1.61%)
167.48M
SGBXSafe and Green Holdings Corporation
$ 0.225
(56.14%)
136.91M
TSLATesla Inc
$ 170.18
(4.97%)
126.42M
ACONAclarion Inc
$ 0.383149
(33.04%)
115.53M
TQQQProShares UltraPro QQQ
$ 52.85
(-1.60%)
86.41M

RDGL Discussion

View Posts
konshe konshe 3 hours ago
Close on green today for Good Friday PPS going up.
👍️ 1 🔥 1
mc73 mc73 5 hours ago
IDE submission is on track, our @RadioGel division for treating cancer in humans is another step closer!! The new RadioGel website will be up by the end of the month! #VivosInc #Radiogel #IsoPet #cancer #PRNT $RDGL

IDE submission is on track, our @RadioGel division for treating cancer in humans is another step closer!! The new RadioGel website will be up by the end of the month! #VivosInc #Radiogel #IsoPet #cancer #PRNT $RDGL pic.twitter.com/2ipUZNvOb7— Vivos Inc. (@VivosIncUSA) April 25, 2024
👍️ 1 🔥 1
mc73 mc73 5 hours ago
IDE submission is on track, our @RadioGel division for treating cancer in humans is another step closer!! The new RadioGel website will be up by the end of the month! #VivosInc #Radiogel #IsoPet #cancer #PRNT $RDGL pic.twitter.com/2ipUZNvOb7— Vivos Inc. (@VivosIncUSA) April 25, 2024
👍️ 1 🔥 1
mikepgator mikepgator 5 hours ago
Accumulation continues.
👍️ 2 💯 1
lovethatgreen lovethatgreen 5 hours ago
Phase one I'm betting will be an overwhelming slam dunk

It's possible I believe they could skip two and go directly to three to complete
👍️ 2
CatfishHunter CatfishHunter 6 hours ago
https://diagramresearch.com/medical-device-clinical-investigation/
👍️ 1
mc73 mc73 7 hours ago
I've seen 3 phases on most of the companies and studies I have looked at.
👍️0
Jimmlu59 Jimmlu59 7 hours ago
Do you know how many phases are in human trials. Also since it’s Classified as a medical device, I assume the criteria is different than creating a drug.
👍️ 1 💯 1
doccjc doccjc 8 hours ago
Pennants are powerful. When you see them, such as the case with $RDGL, you should consider engaging. There's no guarantee but chances are decent (arguably better than 50/50) that you'll get a nice pop. See my prior tweet for reference. pic.twitter.com/iD1wpWB21k— Josh Enomoto (@EnomotoMedia) April 25, 2024

Nice Chart!
👍️ 2
WALLnut WALLnut 8 hours ago
LOL, thanks, now everyone knows the secret.
👍️0
mc73 mc73 9 hours ago
#5 on Break Out Board 🤩
👍️ 2
plinter1 plinter1 9 hours ago
Good point... so the treatment needs to include a heavy dosage of cayenne paper on top of the dressing
👍️ 1
dstep dstep 9 hours ago
But only if you can keep it applied long enough without eating it.
👍️ 1
plinter1 plinter1 10 hours ago
Lol.. but the real secret is when you add the paste to Naan bread as a patch and place directly over the cancer
👍️ 1
WALLnut WALLnut 10 hours ago
Come on man, i already gave more info then I should of. Suppose to be a secret recipe. Ok ok, crunchy but thats all im giving.
👍️0
Big Al T Big Al T 10 hours ago
Crunchy or Creamy?
Madras or Alleppey?
Asking for a friend...
👍️0
WALLnut WALLnut 10 hours ago
I have a tumeric and peanut butter paste I put together in my garage that I think cures skin cancer. I'll submit for a chunk of Moonshot and let you know if I get it or not.
👍️0
wrinklesobw wrinklesobw 11 hours ago
It shouldn’t matter if we are on the otc or not,

It’s a company developing a new way to attack cancer. Period. That’s what the program is about is it not.


Besides the company will have it on the market by the time they get on the NASDAQ. By then it will be too late.


Keep making excuses
👍️0
WALLnut WALLnut 11 hours ago
Moonshot will not grant money to a OTC company. When we get to human trials, and on big board with positive data, I believe Korenko will have better chance at receiving a grant from the Moonshot program. And get this....when we are in second phase of human trials, cancer patients can use the "right to try" program that Trump put in place. Which I think is a great idea. No joke!


RDGL
👍️ 1
kayak_wench kayak_wench 11 hours ago
Huh? The statement they made is
"We are the leaders in radionuclide therapy!"

So radionuclide therapy is the qualifier. In case you don't know the definition of radionuclide therapy is defined as a type of cancer treatment that uses radioactive substances (radionuclides) to kill cancer cells or to prevent them from growing and dividing. This therapy involves administering radioactive substances either orally or intravenously, which then travel through the bloodstream and accumulate in cancerous cells or tissues.

So they are claiming they are leaders in treating cancer with the use of radioactive substances.
👍️ 1 💯 1
kayak_wench kayak_wench 11 hours ago
It will AFTER radiogel proves itself. There are no tangible metrics for them to state that as fact. They can say they believe they are leaders, but an absolute statement is ridiculous at this stage.

ChatGPTs interpretation notes the needs for measureable metrics. Vivos/radiogel doesn't meet any of the noted metrics for 'leader'.

When a company claims to be the "leader" in a particular field, it typically means that they are at the forefront of that industry or market segment. This can imply several things:

Market Share: The company likely has the largest market share compared to its competitors. This could be in terms of revenue, customer base, or other relevant metrics.

Innovation: The company is often the first to introduce new products, services, or technologies within the industry. They may have a reputation for being innovative and setting trends.

Brand Recognition: Being a leader often means having strong brand recognition and a positive reputation within the industry. Customers may associate the company's name with quality, reliability, or other desirable attributes.

Financial Strength: Leaders in an industry typically have strong financial performance, with healthy revenue, profits, and growth rates. This financial strength enables them to invest in research and development, marketing, and other initiatives to maintain their leadership position.

Expertise and Talent: Leading companies often attract top talent in the industry and have deep expertise across various functions. This allows them to execute effectively and stay ahead of competitors.

Overall, when a company claims to be the leader in a particular field, it's asserting its dominance and superiority within that industry, backed by various tangible and intangible factors.
💤 1 🤣 1
Bellionaire Bellionaire 11 hours ago
And I am not disagreeing with you. Just simply replying to another poster about needing a qualifier to understand such a statement from any company.
👍️0
wrinklesobw wrinklesobw 11 hours ago
You are right programs to give money for cancer research isn’t a joke.

The joke is you thinking that the moon shot program is for companies like radiogel.

It’s Biden’s way of repaying his donors by giving the grants to well established universities cancer research and big pharma.

If by some miracle radiogel gets anything from this it will be a piss in the bucket compared to what they have handed out to the universities.

On top of it, it’s been well over a year since this administration has even mentioned it.

The doc asked about it over two years ago and nothing.
👍️ 2 💯 1
wrinklesobw wrinklesobw 11 hours ago
Well considering they are the only ones using a gel for the delivery system. I would think that justifies them in saying they are the leaders
👍️ 1 💯 1
Bellionaire Bellionaire 11 hours ago
I am not a fan of misleading information as well. However, in this case, there is no qualifier. So we don’t know the parameters used for them to make the “leaders” statement. Was it number of animals treated, was it # patents, # clinics, revenues, employees, dollars invested etc, etc??
💤 1 😴 1
den4 den4 12 hours ago
Extremely thin again.. we could fly again today 🚀🚀
👍️ 3 🔥 1
WALLnut WALLnut 12 hours ago
Great idea.. Send the link to Doc or Twitter media personal.



RDGL
👍️0
WALLnut WALLnut 12 hours ago
Never say never.

Any money marked for cancer programs or research is not a joke.



RDGL
👍️0
Big Al T Big Al T 12 hours ago
Interesting site to browse.
Looks legit.
https://www.pearlpathways.com/
👀 1 👍️ 1
wrinklesobw wrinklesobw 12 hours ago
Radiogel won’t see a dime from it. If it was it would have happened by knowing.

They haven’t given a dime to start ups
👍️ 1 💯 1
WALLnut WALLnut 12 hours ago
Moonshot program isn't a joke and its very much still on the table here.




RDGL
🤣 1
nathanial nathanial 12 hours ago
Hanging in there very well this morning.
👍️ 1 💯 1
konshe konshe 12 hours ago
Red to green again, see afternoon rebound with some buy volume.
👍️ 2 🔥 1
wrinklesobw wrinklesobw 13 hours ago
No, I don’t think so. The moon shot program has always been a joke
👍️ 1 💯 1
lovethatgreen lovethatgreen 13 hours ago
Buddy why not go and piss on someone else's cornflakes for a few days
💤 1
wrinklesobw wrinklesobw 13 hours ago
The moonshot program is a joke. Only heard very little about it and what grants have been issued have gone to established cancer programs
👍️ 2 💯 1
Truthsocial Truthsocial 13 hours ago
The long awaited moment of success is just around the corner for RDGL and MAYO clinic and Isopet and YES DR KORENKO...
Fudsters be gone ....and by the way Bidens. moonshot cancer had nothing to do with with the determination and PURE GRIT of CEO DR KORENKO

We are ready to fly baby.....imo
👍️ 2 💯 1
Risk Risk 13 hours ago
Always imagined what they get from all this bashing. So many of them out there :))
👍️0
kayak_wench kayak_wench 13 hours ago
Your wrong. The clock to the end of this quarter is winding down. The company has announced that they will submit an IDE this quarter. Investors are starting to puchase shares in anticipation of that submission. Its a golden, short-term FDA play. THAT is why the stock has started to move. Many of us announced this expected increase to begin and last as the weeks of this quarter play out as the quarter progresses.

Some investors (why do you assume longs? The posts on X just started in the past 6 months, I do not call those longs) have been doing what they are for months. It has nothing to do with price action now.

To claim all increases since 0.06 is because of attempts by retail to promote stock is STOOOPID and ignores the entire fact that the company made some significant announcements since 0.06. Its STOOPID because if what you say were true (that this stock is moving because of investors promoting it and nothing esle) this would be a pump and dump investment. Which is is NOT.
👍️ 2 💯 2
AL93b AL93b 14 hours ago
IDE submission is on track, our @RadioGel division for treating cancer in humans is another step closer!! The new RadioGel website will be up by the end of the month! #VivosInc #Radiogel #IsoPet #cancer #PRNT $RDGL pic.twitter.com/2ipUZNvOb7— Vivos Inc. (@VivosIncUSA) April 25, 2024
👍️ 2 💯 2 🔥 1
wrinklesobw wrinklesobw 14 hours ago
We’ll end of month is Tuesday
👍️ 2 💯 2
Truthsocial Truthsocial 14 hours ago
That was intended to be end of month imo
👍️ 2 🔥 1
konshe konshe 14 hours ago
( of week .33 imo FOMO COMING SOON )

hope you are right, if reached to 0.15 to 0.33, every one will be happy.
👍️ 2 💯 1
DomerJon DomerJon 15 hours ago
And like magic SC8 is gone. Did he get fired from bashing or once the SP goes so high you get moved to another stock to bash as you were not effective? Always wondered that.
👍️0
Risk Risk 15 hours ago
Please we are good without SC8 posting :))
😅 1 😭 1
wrinklesobw wrinklesobw 15 hours ago
Again you’re wrong, there’s been no catalyst and no reason for the share price to move other than from some longs constantly pushing radiogel onto some major traders with very large followers.

If this didn’t happen you would be right, we would still be stuck around .06 and this wouldn’t move until the ide submittal pr
👍️ 1
Truthsocial Truthsocial 16 hours ago
End of week .33 imo FOMO COMING SOON

Skat is trading his skates for scuba gear in Antarctica lol
The iceberg is melting exposing many angles for treating more than cancer imo
👍️ 2
chereb19 chereb19 18 hours ago
Great call Einstein
👍️ 1 🤣 1
chereb19 chereb19 18 hours ago
Wrong, like your call for 5c.
👍️ 1 💯 1
mc73 mc73 1 day ago
All this talk of shareholders spreading the word, nice, but marginally effective.

Catalysts will drive the spread of the news. Once people know the IDE is submitted, the share price will take off. Once IDE is approved, it will fly higher. All of this starts with the catalyst announcements.

National media coverage will give us a major boost and a perfect storm of FOMO could happen here... my bet is any future run is tied back to a catalyst. We went from 6 cents to 11 on a few key catalysts...the best is yet to come!!

Not saying don't spread the word, just saying I don't think the impact is nearly as great as others here believe.
👍️ 1

Your Recent History

Delayed Upgrade Clock